PATENT CLAIM ANALYSIS

Application Number: 15990259
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["424", "451000"]

Abstract:
There are provided compositions and methods for treatment of neurodegeneative diseases and CNS injury. The compositions a pharmaceutically acceptable carrier solution; and a plurality of biodegradable nanoparticles, wherein the nanoparticles comprise a targeting moiety that is able to bind selectively to the surface of a neural stem cell and wherein the nanoparticles further comprise factors such as leukaemia inhibitory factor (LIF); XAV939 and/or one or more of: brain-derived neurotrophic factor (BDNF) or an agonist thereof; epidermal growth factor (EGF) or an agonist thereof; glial cell-derived neurotrophic factor (GDNF) or an agonist thereof; retinoic acid and derivatives thereof; ciliary neurotrophic factor (CTNF) or an agonist thereof; and Wnt5A. The biodegradable nanoparticles may deliver via controlled time release.

Claim (Index 5):
The method of  claim 4 , wherein the animal is selected from the group consisting of:\n sheep; cattle; rodents; rabbits; pigs; cats; dogs; and primates.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 93.0
- Lexical Diversity: 1.725
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['11502338', '12134521', '13360826', '11005518', '10798790']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7686215501611826
- 35 USC 102 Novelty (BERT): 0.525442155641786
- Combined Prediction Score: 0.7443036107092429
- Mean Citation Score: 256.82056800000004
- Max Citation Score: 265.75
- Similarity Product: 132.4162517413497

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test